For most people, untreated herpes means recurring outbreaks that gradually become less frequent over time. It is not a condition that silently destroys your health in the background. But leaving it completely unmanaged does carry real risks: more frequent and prolonged sore outbreaks, a higher chance of transmitting the virus to partners or newborns, and in rare cases, serious complications involving the brain, eyes, or other organs.
What Outbreaks Look Like Without Treatment
Genital herpes caused by HSV-2 typically produces about five outbreaks in the first year after infection. HSV-1 genital infections are milder, with a median of one recurrence per year. The good news is that outbreak frequency drops on its own over time, even without antiviral medication. Patients with HSV-2 who were followed for more than four years experienced a median decrease of two recurrences between years one and five.
Without treatment, each outbreak tends to last longer and produce more painful sores than it would with antivirals. Suppressive therapy cuts the average recurrence rate from about 0.40 outbreaks per month down to 0.11. So while herpes doesn’t get progressively worse year after year, skipping treatment means dealing with more frequent, longer-lasting episodes, especially in those early years.
Ongoing Transmission Risk
One of the most significant consequences of untreated herpes is how easily it spreads. The virus sheds from the skin even when no sores are visible. Studies show asymptomatic shedding occurs on 1% to 3% of days for people with genital HSV-2, but without suppressive therapy, viral DNA is detectable in genital secretions on roughly 10.8% of days. Daily antiviral use drops that to about 2.9% of days.
In a large clinical trial published in the New England Journal of Medicine, untreated partners transmitted HSV-2 to 3.6% of their susceptible partners over eight months, compared to 1.9% for those on daily suppressive therapy. That means forgoing treatment roughly doubles the likelihood of passing the virus to a sexual partner. Most people who contract herpes get it from someone who had no visible symptoms at the time.
Risks During Pregnancy and Childbirth
Untreated herpes poses a serious threat during pregnancy. About 85% of mother-to-child transmission happens during delivery, when the baby passes through an infected birth canal. The risk is dramatically higher for women who acquire herpes for the first time late in pregnancy: neonatal infection occurs in up to 50% of those cases. For women with a history of recurrent herpes, the transmission risk drops to less than 3%.
Neonatal herpes is rare globally (about 10 in every 100,000 births), but it is devastating when it occurs. Infected newborns fall into three categories. About half develop disease limited to the skin, eyes, and mouth, which carries low mortality but can progress if untreated. A third develop brain infection, which causes neurological damage in most survivors. The remaining 17% develop disseminated infection affecting multiple organs, including the liver, lungs, and brain. Without treatment, the mortality rate for disseminated neonatal herpes exceeds 80%.
What makes this especially dangerous is that about 70% of neonatal herpes cases come from mothers who had no visible symptoms at the time of delivery.
Spreading the Virus to Your Own Eyes or Hands
Autoinoculation is the process of transferring the virus from one part of your body to another, typically by touching a sore and then touching your eyes, fingers, or another area. This is most likely during a primary (first) outbreak, when your body hasn’t yet built up antibodies.
HSV keratitis, a herpes infection of the cornea, most commonly develops after the mouth or another body site is already infected. It can cause pain, blurred vision, light sensitivity, and in severe or repeated cases, scarring that affects vision permanently. The simplest prevention is thorough handwashing during outbreaks, especially before touching your face or eyes. Without active management of outbreaks, the window of opportunity for this kind of self-spread is longer and more frequent.
Rare but Serious Neurological Complications
Herpes encephalitis, a brain infection caused by HSV, is uncommon but life-threatening. It is the most common cause of fatal viral encephalitis in the United States. Symptoms begin with fever and headache, then progress over days to confusion, seizures, hallucinations, and declining consciousness. Brain imaging typically reveals swelling in the frontal or temporal lobes.
Without antiviral treatment, 70% of patients with herpes encephalitis die. Even with treatment, the fatality rate is 20% to 30%, and many survivors have lasting neurological damage. HSV-2 can also cause meningitis, an inflammation of the membranes surrounding the brain and spinal cord. While herpes meningitis is usually less severe than encephalitis, it can recur.
Increased Vulnerability to HIV
Untreated HSV-2 increases the risk of acquiring HIV by two- to threefold. The herpes virus creates breaks in the mucosal barrier and draws immune cells to the genital area, both of which give HIV easier entry into the body. This risk persists even when herpes sores aren’t visible, because the inflammation and immune activation continue between outbreaks. People who carry both HSV-2 and HIV are also more likely to transmit HIV to others.
Disseminated Herpes in Immunocompromised People
For people with weakened immune systems, including those with advanced HIV, organ transplant recipients, and people on immunosuppressive medications, untreated herpes can behave very differently. Outbreaks tend to be more severe, last longer, and recur more often.
In rare cases, the virus can disseminate beyond its usual sites and spread to internal organs. Documented cases involve infection of the heart, respiratory system, liver, spleen, kidneys, intestines, and lymph nodes. This disseminated form can trigger fulminant organ failure and sepsis. While exceedingly rare in healthy adults, it underscores why herpes management matters more for anyone with compromised immunity.
What Treatment Actually Changes
Antiviral therapy doesn’t cure herpes or eliminate the virus from your body. What it does is reduce outbreak frequency by roughly 75%, shorten the duration and severity of outbreaks that do occur, cut viral shedding by about 70%, and reduce the risk of transmitting the virus to a partner by approximately half. For most healthy adults, the consequences of untreated herpes are manageable discomfort and social stress rather than medical emergencies. But the cumulative effect of more outbreaks, more shedding days, and more transmission opportunities adds up over years.
The most important risks of leaving herpes untreated are practical ones: passing it to a partner who doesn’t know they’re being exposed, transmitting it to a newborn during delivery, or missing the signs of a rare but dangerous complication like encephalitis. For people with healthy immune systems, herpes is unlikely to cause organ damage or systemic illness on its own, but the virus never fully goes dormant, and unmanaged, it takes more opportunities to cause problems.